A surface modification sheet (X) of the present invention includes a release sheet (10) and a surface modification layer (20) thereon. The surface modification layer (20) contains a polymer having a side chain containing an ethylenic double bond. The side chain of the polymer preferably includes a unit derived from an isocyanate compound containing the ethylenic double bond.

A first ethylene-based interpolymer comprising, in polymerized form, monomer units derived from ethylene and from a benzocyclobutene (VBCB) structure of Structure 1; wherein n is from 3 to 10; and wherein the ethylene-based polymer comprises, in polymerized form, from 0.02 to 0.70 wt % of the Structure 1, based on the weight of the first ethylene-based interpolymer, as determined by .sup.1H NMR is provided. Further provided is a composition which comprises a second ethylene-based inter-polymer formed by thermally treating a first ethylene-based interpolymer.

A first ethylene-based interpolymer comprising, in polymerized form, monomer units derived from ethylene and from a benzocyclobutene (VBCB) structure of Structure 1; wherein n is from 3 to 10; and wherein the ethylene-based polymer comprises, in polymerized form, from 0.02 to 0.70 wt % of the Structure 1, based on the weight of the first ethylene-based interpolymer, as determined by .sup.1H NMR is provided. Further provided is a composition which comprises a second ethylene-based inter-polymer formed by thermally treating a first ethylene-based interpolymer.

A wax-polymer compound includes (a) a polymer component that is a polymerized unsaturated monomer, optionally copolymerized with a vinyl-aromatic monomer, and (b) a halogenated hydrocarbon wax component. The polymer component is grafted to the halogenated hydrocarbon wax component, and the wax-polymer compound has a number average molecular weight of about 1,000 to about 100,000, A method of making the wax-polymer compound and a coated silica particle are also disclosed. A rubber composition includes a rubber elastomer comprising a polymerized unsaturated monomer and optionally a polymerized vinyl-aromatic monomer, the elastomer having a number average molecular weight of about 100,000 to about 1,000,000. It further includes a filler in an amount of about 5 to about 200 phr, the filler comprising carbon black, silica, or both; and a wax-polymer additive.

Disclosed are branched PEG molecules, including branched PEG-lipids and branched-PEG proteins, as well as related compositions and methods for making branched PEG molecules. Also disclosed are related compositions, systems, and methods for in vivo delivery of therapeutic and diagnostic agents.

The present disclosure provides compounds and nanostructures having one or more quaternary ammonium salts, compositions including the compounds and nanostructures, and methods useful for treating conditions using the compounds, nanostructures, and compositions. In at least one aspect, a compound is represented by formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof, wherein: Q is fluoro, chloro, bromo, or iodo; each of s, b, and n is independently an integer from about 10 to about 100; and each of v, j, p, z, q, x and m is independently an integer from 1 to about 20.

The present disclosure provides compounds and nanostructures having one or more quaternary ammonium salts, compositions including the compounds and nanostructures, and methods useful for treating conditions using the compounds, nanostructures, and compositions. In at least one aspect, a compound is represented by formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof, wherein: Q is fluoro, chloro, bromo, or iodo; each of s, b, and n is independently an integer from about 10 to about 100; and each of v, j, p, z, q, x and m is independently an integer from 1 to about 20.

There is provided a curable composition, which forms a cured product with high light transmittance, a high refractive index, and high scratch resistance, a cured product thereof, and an optical member. A curable composition contains zirconium oxide nanoparticles, a dispersant, and a (meth)acrylate compound. The dispersant has an acid value in the range of 100 to 300 mgKOH/g. The (meth)acrylate compound contains a (meth)acrylate compound having a poly(alkylene oxide) structure.

Synthesis of modified chitosan particles for oral insulin delivery includes amidation of chitosan with a fatty acid, a modified fatty acid, and/or an amino acid. The amidated chitosan can be grafted with N-isopropylacrylamide (NIPAm) and cross-linked to provide the modified chitosan particles.

Provided herein are materials and methods of reducing contamination in a biological substance or treating contamination in a subject by one or more toxins comprising contacting the biological substance with an effective amount of a sorbent capable of sorbing the toxin, wherein the sorbent comprises a plurality of pores ranging from 50 Å to 40,000 Å with a pore volume of 0.5 cc/g to 5.0 cc/g and a size of 0.05 mm to 2 cm and sorbing the toxin. Also provided are kits to reduce contamination by one or more toxins in a biological substance comprising a sorbent capable of sorbing a toxin, wherein the sorbent comprises a plurality of pores ranging from 50 Å to 40,000 Å with a pore volume of 0.5 cc/g to 5.0 cc/g and a size of 0.05 mm to 2 cm and a vessel to store said sorbent when not in use together with packaging for same.